The Food and Drug Administration (FDA) has approved a domestically-developed and produced antibody reagent for the COVID-19 coronavirus disease, the first of its kind licensed in Taiwan, an FDA official said Friday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Precinct chief addresses public concerns over Taipei stabbing response
12/21/2025 09:31 PM - Society
Taipei mass stabber began purchasing supplies for attack in 2024: Police
12/21/2025 08:37 PM - Society
Off-duty NTUH doctor recounts aiding Taipei stabbing spree victims
12/21/2025 08:16 PM - Culture
Taiwan physician-turned artist brings whimsy to Lancet covers
12/21/2025 06:48 PM - Society
Suspected drug smuggler arrested after chase through Kaohsiung airport
12/21/2025 06:40 PM